Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-10-01 · accession 0001879231-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-02 | 2024-10-01 | LSTA | Buck Kristen K | EVP, CMO, R, D | F - Tax | $2.93 | -6,363 | 62.7K | -9% | -$18.6K | |
| 2024-10-02 | 2024-10-01 | LSTA | Buck Kristen K | EVP, CMO, R, D | A - Grant | $2.93 | +15.0K | 69.0K | +28% | +$44.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | F | D | 6,363 | $2.93 | 62,672 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of performance-based stock units. (F2) Includes 30,325 unvested restricted stock. |
| 2 | Common | Common Stock | 2024-10-01 | A | A | 15,000 | $2.93 | 69,035 | D | — | — | (F1) Reflects 15,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024, and which vested in full on that same day. (F2) Includes 30,325 unvested restricted stock. |